Literature DB >> 17452471

Fungicidal monoclonal antibody C7 binds to Candida albicans Als3.

Sonia Brena1, Miren J Omaetxebarría, Natalia Elguezabal, Jonathan Cabezas, María D Moragues, José Pontón.   

Abstract

Monoclonal antibody (MAb) C7 reacted with a >200-kDa component from the Candida albicans cell wall identified by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry as Als3. It also bound the recombinant N terminus of Als3. Binding of MAb C7 to Als3 may explain the biological activities exerted by the MAb on C. albicans.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17452471      PMCID： PMC1932956          DOI： 10.1128/IAI.01840-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  10 in total

1.  Functional analysis of the Candida albicans ALS1 gene product.

Authors:  Lucio Loza; Yue Fu; Ashraf S Ibrahim; Donald C Sheppard; Scott G Filler; John E Edwards
Journal:  Yeast       Date:  2004-04-30       Impact factor: 3.239

2.  The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice.

Authors:  Brad J Spellberg; Ashraf S Ibrahim; Valentina Avenissian; Scott G Filler; Carter L Myers; Yue Fu; John E Edwards
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  A fungicidal monoclonal antibody protects against murine invasive candidiasis.

Authors:  María J Sevilla; Beatriz Robledo; Aitor Rementeria; María D Moragues; José Pontón
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 4.  Antifungal and antitumor activities of a monoclonal antibody directed against a stress mannoprotein of Candida albicans.

Authors:  M J Omaetxebarría; M D Moragues; N Elguezabal; A Rodríguez-Alejandre; S Brena; J Schneider; L Polonelli; J Pontón
Journal:  Curr Mol Med       Date:  2005-06       Impact factor: 2.222

Review 5.  The ALS gene family of Candida albicans.

Authors:  L L Hoyer
Journal:  Trends Microbiol       Date:  2001-04       Impact factor: 17.079

6.  Analysis of cell wall extracts of Candida albicans by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot techniques.

Authors:  J Ponton; J M Jones
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

7.  A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.

Authors:  María D Moragues; Miren J Omaetxebarria; Natalia Elguezabal; María J Sevilla; Stefania Conti; Luciano Polonelli; José Pontón
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Identification of Candida albicans ALS2 and ALS4 and localization of als proteins to the fungal cell surface.

Authors:  L L Hoyer; T L Payne; J E Hecht
Journal:  J Bacteriol       Date:  1998-10       Impact factor: 3.490

9.  Heat-shock mannoproteins as targets of secretory IgA in Candida albicans.

Authors:  L Polonelli; M Gerloni; S Conti; P Fisicaro; C Cantelli; P Portincasa; F Almondo; P L Barea; F L Hernando; J Ponton
Journal:  J Infect Dis       Date:  1994-06       Impact factor: 5.226

10.  Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the N-terminal fragment of Candida albicans hyphal wall protein 1.

Authors:  Ana Laín; Natalia Elguezabal; Sonia Brena; Juan Carlos García-Ruiz; Amalia Del Palacio; María D Moragues; José Pontón
Journal:  BMC Microbiol       Date:  2007-04-21       Impact factor: 3.605
  10 in total
  14 in total

1.  Fungicidal monoclonal antibody C7 interferes with iron acquisition in Candida albicans.

Authors:  Sonia Brena; Jonathan Cabezas-Olcoz; María D Moragues; Iñigo Fernández de Larrinoa; Angel Domínguez; Guillermo Quindós; José Pontón
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.

Authors:  Hong Xin; Jim E Cutler
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

Review 3.  Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases.

Authors:  Arturo Casadevall; Liise-Anne Pirofski
Journal:  Cell Host Microbe       Date:  2012-05-17       Impact factor: 21.023

Review 4.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

Review 5.  Candida albicans Als3, a multifunctional adhesin and invasin.

Authors:  Yaoping Liu; Scott G Filler
Journal:  Eukaryot Cell       Date:  2010-11-29

6.  Effects of immune suppression in murine models of disseminated Candida glabrata and Candida tropicalis infection and utility of a synthetic peptide vaccine.

Authors:  Hong Xin
Journal:  Med Mycol       Date:  2019-08-01       Impact factor: 4.076

7.  Inhibition of Candida albicans adhesion by recombinant human antibody single-chain variable fragment specific for Als3p.

Authors:  Sonia S Laforce-Nesbitt; Mark A Sullivan; Lois L Hoyer; Joseph M Bliss
Journal:  FEMS Immunol Med Microbiol       Date:  2008-07-24

Review 8.  Attempts at a peptide vaccine against paracoccidioidomycosis, adjuvant to chemotherapy.

Authors:  Luiz R Travassos; Elaine G Rodrigues; Leo K Iwai; Carlos P Taborda
Journal:  Mycopathologia       Date:  2008 Apr-May       Impact factor: 2.574

9.  Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence.

Authors:  Antonella Torosantucci; Paola Chiani; Carla Bromuro; Flavia De Bernardis; Angelina S Palma; Yan Liu; Giuseppina Mignogna; Bruno Maras; Marisa Colone; Annarita Stringaro; Silvia Zamboni; Ten Feizi; Antonio Cassone
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

10.  Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities.

Authors:  Luciano Polonelli; José Pontón; Natalia Elguezabal; María Dolores Moragues; Claudio Casoli; Elisabetta Pilotti; Paola Ronzi; Andrey S Dobroff; Elaine G Rodrigues; Maria A Juliano; Domenico Leonardo Maffei; Walter Magliani; Stefania Conti; Luiz R Travassos
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.